Filing Details
- Accession Number:
- 0000950170-24-077468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-25 18:04:54
- Reporting Period:
- 2024-06-23
- Accepted Time:
- 2024-06-25 18:04:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1567514 | Intra-Cellular Therapies Inc. | ITCI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1016835 | B Rory Riggs | C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-23 | 1,567 | $0.00 | 101,062 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-06-24 | 20,000 | $16.86 | 121,062 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-24 | 4,462 | $75.57 | 116,600 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-06-23 | 1,567 | $0.00 | 1,567 | $0.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-06-24 | 20,000 | $0.00 | 20,000 | $16.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 0 | 2024-06-30 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of common stock.
- On June 24, 2024, the reporting person exercised options to purchase 20,000 shares of common stock that are expiring on June 30, 2024 and the issuer retained 4,462 shares of common stock to pay the exercise price of the options.
- On June 23, 2023, the reporting person was granted 1,567 restricted stock units, which vested on the first anniversary of the grant date (June 23, 2024).
- This option was granted on June 30, 2014 and will expire on June 30, 2024. All shares underlying this option have vested.
Billionaire Hedge Funds
